Company: OXBRW
Filing Date: 2025-03-26
Form Type: 10-K
Source: 0001641172-25-000736
Chunk: 394

Company: OXBRIDGE RE HOLDINGS Ltd
Filing Date: 2025-03-26
Form: 10-K
Item: Item 1
Chunk 394
---
”). Under each
of the Plans, the Company has discretion to grant equity and cash incentive awards to eligible individuals, including the issuance of
up to 1,000,000 of the Company’s ordinary shares. During the year ended December 31, 2024, the Company granted an aggregated of
136,427 of restricted stock to directors, officers and employees under the 2021 Plan. At December 31, 2024, there were 758,926 shares
and 11,750 shares available for grant under the 2021 Plan and the 2014 Plan, respectively.

Stock
options

Stock
options granted and outstanding under the Plans vests quarterly over four years and are exercisable over the contractual term of ten
years.

A
summary of the stock option activity for the years ended December 31, 2024 and 2023 is as follows (option amounts not in thousands):

SCHEDULE
OF STOCK OPTION ACTIVITY

    Number of Options  
    Weighted- Average Exercise Price  
    Weighted- Average
                                                      Remaining
                                                      Contractual Term 
    Aggregate
                                                                  Intrinsic
                                                                  Value 

    Outstanding at December 31, 2023 
     846,250  
    $4.63  
    4.8 years 
    $         - 
  
    Exercisable at December 31, 2023 
     783,750  
    $4.52  
    4.6 years 
    $- 

    Outstanding at December 31, 2024 
     846,250  
    $4.63  
    3.7 years 
    $- 
  
    Exercisable at December 31, 2024 
     846,250  
    $4.63  
    3.7 years 
    $- 

    F-23

OXBRIDGE
RE HOLDINGS LIMITED AND SUBSIDIARIES

Notes
to Consolidated Financial Statements, Continued

11.
SHARE-BASED COMPENSATION (continued)

Compensation
expense recognized for each of the years ended December 31, 2024 and 2023 totaled $20,000,
and is included in general and administrative
expenses. At December 31, 2024 and 2023, there was approximately $0
and $20,000,
respectively, of total unrecognized compensation expense related to non-vested stock options granted under